Diversified healthcare company CVS Health (NYSE:CVS) announced better-than-expected revenue in Q1 CY2025, with sales up 7% ...

CVS reported first quarter earnings Thursday, blowing past Wall Street's expectations and ending anxiety over Medicare ...

CVS Health sees strong Q1 2025 growth, but risks loom with downgraded revenue guidance and Medicare challenges. Read my analysis on CVS stock's earnings here.

CVS Health Corporation ( NYSE: CVS) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET David Joyner - President, Chief Executive Officer Tom Cowhey - Executive Vice President, Chief Financial ...

CVS Health Corp posted a strong first quarter in 2025, with earnings per share (EPS) of $2.25, surpassing the forecast of $1.64. The company’s revenue reached nearly $95 billion, exceeding ...

CVS (CVS) reported first quarter earnings Thursday, beating Wall Street's expectations. The company also raised its full-year 2025 guidance, with adjusted earnings per share now expected in the ...

CVS Health (NYSE:CVS) reported robust year-over-year growth in Q1 2025 earnings, with significant increases in sales, revenue ...

CVS Health shares powered 7% higher Thursday after the pharmacy and healthcare giant's first-quarter results easily topped ...

CVS Health (NYSE: CVS) raised its full-year 2025 adjusted EPS guidance to a range of $6.00 to $6.20, up from its previous forecast of $5.75 to $6.00 and above the analyst consensus of $5.91.

CVS Health reported strong first-quarter results that exceeded Wall Street’s expectations. The company’s revenue ...

CVS Health Corp. reported a strong start to 2025, with first-quarter revenue climbing 7%, driven by growth across all business segments.